Screening compound: SKRGZVJDEGHVRZ-MRXNPFEDSA-N

Screening compound: SKRGZVJDEGHVRZ-MRXNPFEDSA-N
Screening compound: SKRGZVJDEGHVRZ-MRXNPFEDSA-N alternative view

Chemical Structure Depiction of ChemDiv screening compound
SKRGZVJDEGHVRZ-MRXNPFEDSA-N

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P392-0052

Molecular Formula

C20H22ClN3O3 (C20 H22 ClN3 O3)

Compound Name

2-({1-[2-(4-chlorophenyl)acetyl]tetrahydro-1H-pyrrol-3-yl}oxy)-N~3~,N~3~-dimethylnicotinamide

IUPAC name

2-({1-[2-(4-chlorophenyl)acetyl]pyrrolidin-3-yl}oxy)-NN-dimethylpyridine-3-carboxamide

SMILES

CN(C)C(c1cccnc1OC(CC1)CN1C(Cc(cc1)ccc1Cl)=O)=O

InChI

InChI=1S/C20H22ClN3O3/c1-23(2)20(26)17-4-3-10-22-19(17)27-16-9-11-24(13-16)18(25)12-14-5-7-15(21)8-6-14/h3-8,10,16H,9,11-13H2,1-2H3/t16-/m1/s1

InChI Key

SKRGZVJDEGHVRZ-MRXNPFEDSA-N

MDL Number (MFCD)

MFCD28994550

SKRGZVJDEGHVRZ-MRXNPFEDSA-N in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Anti-Aging Library (44940 compounds)

Ligand-Gated Ion Channels Library (3887 compounds)

PI3K-Targeted Library (17255 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Alpha-Helix Mimetics Library (25899 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Inhibitors of beta-Catenin Signaling (7445 compounds)

MCE-18 Trends in Medicinal Chemistry (51288 compounds)

MEF2-HDAC (class II) Modulators Library (5147 compounds)

SH2 PTB Focused Library (6188 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Nervous system
  • Eye
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Musculoskeletal
  • Female
  • Hemic and lymphatic
  • Cardiovascular
Mechanism of action:
  • Epigenetic
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • Epigenetic
Targets:
  • Ion Channels
  • Kinases
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds

References: we are preparing a list of scientific research reports with SKRGZVJDEGHVRZ-MRXNPFEDSA-N chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound SKRGZVJDEGHVRZ-MRXNPFEDSA-N?
Check Price and Availability of SKRGZVJDEGHVRZ-MRXNPFEDSA-N, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of SKRGZVJDEGHVRZ-MRXNPFEDSA-N you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for SKRGZVJDEGHVRZ-MRXNPFEDSA-N
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for SKRGZVJDEGHVRZ-MRXNPFEDSA-N
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of SKRGZVJDEGHVRZ-MRXNPFEDSA-N available by request